At the 2015 DIA Annual Meeting in June, we sat down PharmaVOICE Editor Taren Grom and Claire Meunier, Vice President of Research Engagement at the Michael J. Fox Foundation for a conversation about patient centricity and the role technology is playing and will continue to play as we move forward.
In June of 2014, Japan’s prime minister, Shinzo Abe said he wanted to increase the market for robots in Japan to $22 billion by 2020 and launched a “robot revolution realization council” to create a five-year blueprint to push the industry forward. On the heels of this announcement the New Energy and Industrial Technology Development Organization (NEDO) has recruited Kawasaki and Panasonic to create a robot to perform more intricate tasks, including brain surgery. Their goal is to have products in clinical trials as soon as 2019. This increase in robotic advancement is expected to minimize error and maximize efficiency and precision during medical procedures. In addition, the use of robots to complete jobs usually done by humans has the potential to decrease overall costs in the coming years.
Not that long ago, the healthcare sector was considered an IT laggard. Today, cloud-based infrastructures and solutions are the norm.
Considering a social media campaign for your clinical trial? While there are proven advantages to using social media as a patient recruitment tactic, additional considerations must be explored when deciding if social media fits your campaign’s needs. First, scope out your audience by evaluating the opportunity with a social media listening program. For example, how active and engaged is this study community on social media? Or, how many Facebook groups, outlets, etc. are out there for these patients to find each other? Next, evaluate the outlet – What are all my options when building a social media page? Or, what outlets can I use if I just want to advertise?
A few weeks ago, and nearly five years after its open hearing on the topic, the Food and Drug Administration (FDA) finally released its proposed guidelines for how drug and device makers should navigate social media. Much has been written on the new guidelines including a few informative posts by Ed Silverman at the Wall Street Journal. As Silverman notes, among the 50 largest drug makers, half are still not using social media to engage consumers or patients, according to a survey by the IMS Institute for Health Informatics. He also suggests that the FDA will likely use the guidances as trial-and-error blueprints themselves as they run across questions that were not answered or situations that may not have been anticipated.
Even if you were able to correlate advertising referrals to consented patients with a high degree of accuracy (and then to screen-fail and randomization) the fact of the matter is, "So what?"
Four scenarios spring to mind with regard to the quest for this correlation:
Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study BuddySM Mobile Apps to Help Boost Patient Engagement
Mobile Apps to Streamline Valuable Resource and Information Sharing, Better Connect Advocacy Groups, Pharmaceutical Sponsors and Patients
DIA 2014 50th Annual Meeting, SAN DIEGO, Calif. and BOSTON, Mass., June 16, 2014--BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study BuddySM and My Clinical Study BuddySM Protocol Pointers Edition. Available for Apple® and Android™ mobile phones and tablets, both apps are available today on iTunes® and the Google Play™ store and are being demoed at this week's DIA 2014 50th Annual Meeting at the San Diego Convention Center, San Diego, Calif., June 16-19 at BBK booth #2309.
It's that time again... The Annual Meeting of the Drug Information Association is here! This year is the DIA's 50th anniversary, and to mark the occasion, the event's theme is "Celebrate the Past - Invent the Future." We anticipate numerous presentations and discussions about where the industry has come and where it's headed. We are delighted to bring a patient recruitment perspective to the conversation.
The 50th Annual Meeting of the DIA is right around the corner! Today we're excited to kick off our promotion with a guest blog from our friend, Lani Hashimoto. Lani is an expert in global patient recruitment and retention with 19 years of clinical trial experience within global pharmaceuticals. In this post, Lani tells us about the Exhibit Hall Guide volunteer program she has coordinated at this year's Annual Meeting in an effort to facilitate networking opportunities between Patient Fellows and the pharmaceutical industry. So far, we've recruited two BBKers to volunteer and hope that you and your colleagues will participate, too!
Struggling musician? Tell me about it. I've been playing, or should I say, trying to play the guitar for a few years now. There are many different methodologies to playing a guitar, but at the end of the day, it's an instrument. And when I am not pretending to be Tom Petty on the weekends, I spend my days working in our technology department here at BBK Worldwide. The instrument I use on a daily basis is TrialCentralNetTM (TCN®), a metric-driven patient recruitment portal. So, where am I going with all this? Well, here is a quote from Johann Sebastian Bach that will set the tone for this blog post: "It's easy to play any musical instrument: all you have to do is touch the right key at the right time and the instrument will play itself."